Liver glucose metabolism in humans
Open accessThe DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.
Abstract
Information about normal hepatic glucose metabolism may help to understand pathogenic mechanisms underlying obesity and diabetes mellitus. In addition, liver glucose metabolism is involved in glycosylation reactions and connected with fatty acid metabolism. The liver receives dietary carbohydrates directly from the intestine via the portal vein. Glucokinase phosphorylates glucose to glucose 6-phosphate inside the hepatocyte, ensuring that an adequate flow of glucose enters the cell to be metabolized. Glucose 6-phosphate may proceed to several metabolic pathways. During the post-prandial period, most glucose 6-phosphate is used to synthesize glycogen via the formation of glucose 1-phosphate and UDP–glucose. Minor amounts of UDP–glucose are used to form UDP–glucuronate and UDP–galactose, which are donors of monosaccharide units used in glycosylation. A second pathway of glucose 6-phosphate metabolism is the formation of fructose 6-phosphate, which may either start the hexosamine pathway to produce UDP-N-acetylglucosamine or follow the glycolytic pathway to generate pyruvate and then acetyl-CoA. Acetyl-CoA may enter the tricarboxylic acid (TCA) cycle to be oxidized or may be exported to the cytosol to synthesize fatty acids, when excess glucose is present within the hepatocyte. Finally, glucose 6-phosphate may produce NADPH and ribose 5-phosphate through the pentose phosphate pathway. Glucose metabolism supplies intermediates for glycosylation, a post-translational modification of proteins and lipids that modulates their activity. Congenital deficiency of phosphoglucomutase (PGM)-1 and PGM-3 is associated with impaired glycosylation. In addition to metabolize carbohydrates, the liver produces glucose to be used by other tissues, from glycogen breakdown or from de novo synthesis using primarily lactate and alanine (gluconeogenesis).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During hyperglycemia, liver is the major site of glucose utilization, accounting for uptake of approximately 50% of the ingested glucose [102-104].”
From Effect of blood glucose level on standardized uptake value (SUV) in 18F-FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements (2019) · cites this paper as [102]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolic Effects of Fructose and the Worldwide Increase in Obesity
Tappy, L., & Lê, K.-A. (2010) · Physiological Reviews · doi:10.1152/physrev.00019.2009 · Cited by 1,256 · cited 1×
“Fructose taken up by hepatocytes may be converted into either fructose 6-phosphate by hexokinase isoenzymes or fructose 1-phosphate by fructokinase [16].”
BackgroundThe key role of anaplerosis and cataplerosis for citric acid cycle function
Owen, O. E., Kalhan, S. C., & Hanson, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200006200 · Cited by 1,172 · cited 1×
“Several reactions in the TCA cycle provide NADH and FADH 2 that are subsequently oxidized in the mitochondrial respiratory chain to produce ATP [53].”
BackgroundNonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus
Vionnet, N., Stoffel, M., Takeda, J., Yasuda, K., Bell, G. I., Zouali, H., Lesage, S., Velho, G., Iris, F., Passa, P., et al. (1992) · Nature · doi:10.1038/356721a0 · Cited by 604 · cited 1×
“In 1992, genetic linkage between MODY2 and the GCK gene was repor-ted and the identification of a nonsense mutation in this gene was linked to MODY2 in one family [18].”
BackgroundFamilial Hyperinsulinism Caused by an Activating Glucokinase Mutation
Glaser, B., Kesavan, P., Heyman, M., Davis, E., Cuesta, A., Buchs, A., Stanley, C. A., Thornton, P. S., Permutt, M. A., Matschinsky, F. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380404 · Cited by 564 · cited 1×
“When expressed in vitro , the mutant enzyme has increased affinity for glucose that results in higher rate of glucose metabolism and enhanced insulin secretion [21].”
BackgroundGenetic Analysis of Italian Patients with Congenital Hyperinsulinism of Infancy
Sogno Valin, P., Proverbio, M. C., Diceglie, C., Gessi, A., di Candia, S., Mariani, B., Zamproni, I., Mangano, E., Asselta, R., Battaglia, C., et al. (2013) · Hormone Research in Paediatrics · doi:10.1159/000350827 · Cited by 552
Structural Basis for Allosteric Regulation of the Monomeric Allosteric Enzyme Human Glucokinase
Kamata, K., Mitsuya, M., Nishimura, T., Eiki, J.-I., & Nagata, Y. (2004) · Structure · doi:10.1016/j.str.2004.02.005 · Cited by 502 · cited 3×
“The inflexion point on the sigmoidal glucose saturation curve is at 8 mM [13].”
BackgroundInfluentialThe Disposal of an Oral Glucose Load in Healthy Subjects: A Quantitative Study
Ferrannini, E., Bjorkman, O., Reichard, G. A., Pilo, A., Olsson, M., Wahren, J., & DeFronzo, R. A. (1985) · Diabetes · doi:10.2337/diab.34.6.580 · Cited by 439
Neonatal Diabetes Mellitus Due to Complete Glucokinase Deficiency
Njølstad, P. R., Søvik, O., Cuesta-Muñoz, A., Bjørkhaug, L., Massa, O., Barbetti, F., Undlien, D. E., Shiota, C., Magnuson, M. A., Molven, A., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105243442104 · Cited by 424
Fukumoto, H., Seino, S., Imura, H., Seino, Y., Eddy, R. L., Fukushima, Y., Byers, M. G., Shows, T. B., & Bell, G. I. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5434 · Cited by 422
Beer, N. L., Tribble, N. D., McCulloch, L. J., Roos, C., Johnson, P. R. V., Orho-Melander, M., & Gloyn, A. L. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp357 · Cited by 401 · cited 1×
“Fructose 1-phosphate activates glucokinase whereas fructose 6-phosphate suppresses glucokinase activity by acting on the glucokinase regulatory protein [15].”
BackgroundCritical phosphorylation sites for acetyl-CoA carboxylase activity.
Ha, J., Daniel, S., Broyles, S. S., & Kim, K. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31770-2 · Cited by 326
Linking mitochondrial bioenergetics to insulin resistance via redox biology
Fisher-Wellman, K. H., & Neufer, P. D. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.12.008 · Cited by 316
Multiple Phenotypes in Phosphoglucomutase 1 Deficiency
Tegtmeyer, L. C., Rust, S., van Scherpenzeel, M., Ng, B. G., Losfeld, M.-E., Timal, S., Raymond, K., He, P., Ichikawa, M., Veltman, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1206605 · Cited by 284
Patel, K. P., O'Brien, T. W., Subramony, S. H., Shuster, J., & Stacpoole, P. W. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.09.032 · Cited by 278
Glucose-6-phosphatase deficiency
Froissart, R., Piraud, M., Boudjemline, A. M., Vianey-Saban, C., Petit, F., Hubert-Buron, A., Eberschweiler, P. T., Gajdos, V., & Labrune, P. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-27 · Cited by 265
O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth
Rao, X., Duan, X., Mao, W., Li, X., Li, Z., Li, Q., Zheng, Z., Xu, H., Chen, M., Wang, P. G., et al. (2015) · Nature Communications · doi:10.1038/ncomms9468 · Cited by 257 · cited 1×
“Transketolase may also be responsible for the cleaving of a two carbon unit from xylulose 5-phosphate and adding that two carbon unit to erythrose 4-phosphate resulting in glyceraldehyde 3-phosphate and fructose 6-phosphate [59].”
BackgroundZhang, Y., Yu, X., Ichikawa, M., Lyons, J. J., Datta, S., Lamborn, I. T., Jing, H., Kim, E. S., Biancalana, M., Wolfe, L. A., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.02.013 · Cited by 247
Stoffel, M., Froguel, P., Takeda, J., Zouali, H., Vionnet, N., Nishi, S., Weber, I. T., Harrison, R. W., Pilkis, S. J., & Lesage, S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7698 · Cited by 228
Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects.
Velho, G., Petersen, K. F., Perseghin, G., Hwang, J. H., Rothman, D. L., Pueyo, M. E., Cline, G. W., Froguel, P., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118974 · Cited by 217
Glucose-6-phosphatase Catalytic Subunit Gene Family
Hutton, J. C., & O'Brien, R. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.025544 · Cited by 207 · cited 1×
“Glucose 6-phosphate translocase transports glucose 6-phosphate from the cytosol into the lumen of the endoplasmic reticulum and glucose 6-phosphatase isoenzymes catalyse the dephosphorylation of glucose 6-phosphate to yield free glucose and P i [73].”
BackgroundSassi, A., Lazaroski, S., Wu, G., Haslam, S. M., Fliegauf, M., Mellouli, F., Patiroglu, T., Unal, E., Ozdemir, M. A., Jouhadi, Z., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.02.025 · Cited by 195
Patel, K. P., O'Brien, T. W., Subramony, S. H., Shuster, J., & Stacpoole, P. W. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.03.017 · Cited by 192
Mutations in the glucose-6-phosphatase-α (G6PC) gene that cause type Ia glycogen storage disease
Chou, J. Y., & Mansfield, B. C. (2008) · Human Mutation · doi:10.1002/humu.20772 · Cited by 181
Santer, R., Schneppenheim, R., Suter, D., Schaub, J., & Steinmann, B. (1998) · European Journal of Pediatrics · doi:10.1007/s004310050937 · Cited by 181
Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing
Timal, S., Hoischen, A., Lehle, L., Adamowicz, M., Huijben, K., Sykut-Cegielska, J., Paprocka, J., Jamroz, E., van Spronsen, F. J., Körner, C., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds123 · Cited by 175
Edghill, E. L., Bingham, C., Slingerland, A. S., Minton, J. A. L., Noordam, C., Ellard, S., & Hattersley, A. T. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01999.x · Cited by 174
Novel Presentations of Congenital Hyperinsulinism due to Mutations in the MODY genes:HNF1A and HNF4A
Stanescu, D. E., Hughes, N., Kaplan, B., Stanley, C. A., & De León, D. D. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1356 · Cited by 172
Consoli, A., Kennedy, F., Miles, J., & Gerich, J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113206 · Cited by 167 · cited 2×
“…converted to pyruvate and then into oxaloacetate and phosphoenolpyruvate to synthesize glucose, glycerol derived from triacylglycerols is incorporated to the gluconeogenesis pathway by being converted into dihydroxy-acetone phosphate, producing glucose avoiding phosphoenolpyr-uvate formation [69].”
BackgroundDe novo lipogenesis during controlled overfeeding with sucrose or glucose in lean and obese women
McDevitt, R. M., Bott, S. J., Harding, M., Coward, W. A., Bluck, L. J., & Prentice, A. M. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.6.737 · Cited by 166 · cited 3×
“Excess dietary carbohydrate increases body fat stores both by suppression of the oxidation of dietary fat and by conversion of the surplus carbohydrate to fat [35].”
BackgroundInfluentialThoden, J. B., Wohlers, T. M., Fridovich-Keil, J. L., & Holden, H. M. (2000) · Biochemistry · doi:10.1021/bi000215l · Cited by 162 · cited 2×
“Finally, the enzyme UDP-N -acetylglucosamine pyrophosphorylase (UAP1) or N -acetylglucosamine 1-phosphate uridyltransferaseconverts N -acetylglucosamine 1-phosphate into UDP-N -acetylglucosamine, the end product of the hexosamine pathway [40].”
BackgroundFanelli, C., Calderone, S., Epifano, L., De Vincenzo, A., Modarelli, F., Pampanelli, S., Perriello, G., De Feo, P., Brunetti, P., & Gerich, J. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116746 · Cited by 159 · cited 1×
“Likewise, an increment in blood glucose level is demonstrable after alanine administration in subjects fasted 3– 4 weeks [68].”
BackgroundPeneff, C., Ferrari, P., Charrier, V., Taburet, Y., Monnier, C., Roig-Zamboni, V., Winter, J., Harnois, M., Fassy, F., & Bourne, Y. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6191 · Cited by 155 · cited 2×
“UAP1 catalyses the reversible transfer of an uridyl group from UTP to N -acetylglucosamine 1-phosphate in the presence of Mg 2 + or Mn 2 + , producing UDP-N -acetylglucosamine and releasing PP i from UTP [50].”
BackgroundQuantifying gluconeogenesis during fasting
Chandramouli, V., Ekberg, K., Schumann, W. C., Kalhan, S. C., Wahren, J., & Landau, B. R. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.6.e1209 · Cited by 154 · cited 1×
“Likewise, during insulin-inducedhypoglycaemia(55 mg/dl)thatmimicsstarvation periods in healthy volunteers, glycogenolysis accounts initially for 85% of hepatic glucose output, but once hypoglycaemia becomes established the contribution of gluconeogenesis increases to 77–94% [61].”
BackgroundZhang, Q., Liu, X., Gao, W., Li, P., Hou, J., Li, J., & Wong, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.524140 · Cited by 146
Verhoeven‐Duif, N. M., Huck, J. H. J., Roos, B., Struys, E. A., Salomons, G. S., Douwes, A. C., van der Knaap, M. S., & Jakobs, C. (2001) · The American Journal of Human Genetics · doi:10.1086/320108 · Cited by 141
McKnight, G. L., Mudri, S., Mathewes, S. L., Traxinger, R. R., Marshall, S., Sheppard, P. O., & O’Hara, P. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74026-5 · Cited by 134 · cited 1×
“In vitro studies show that saturated fatty acids palmitate (C16:0) and stearate (C18:0) increase the expression of gluc-osamine 6-phosphate synthase mRNA and protein in cultured myotubes from human skeletal muscle whereas unsaturated fatty acids or glucose have no effect [44].”
BackgroundSansbury, F., Flanagan, S., Houghton, J., Shen, S.-X., Senani, A. A., Habeb, A., Abdullah, M., Kariminejad, A., Ellard, S., & Hattersley, A. (2012) · Diabetologia · doi:10.1007/s00125-012-2595-0 · Cited by 134 · cited 1×
“The findings that patients with homozygous SLC2A2 mutations may present with neonatal diabetes suggest that GLUT2 expressed in pancreatic β -cells is involved in glucose-stimulated insulin secretion [10].”
BackgroundPathways for glucose disposal after meal ingestion in humans
Woerle, H. J., Meyer, C., Dostou, J. M., Gosmanov, N. R., Islam, N., Popa, E., Wittlin, S. D., Welle, S. L., & Gerich, J. E. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00365.2002 · Cited by 133 · cited 2×
“After a meal, the majority of glycogen is formed via the direct pathway (73%), but the indirect pathway accounts for 27% of the glycogen formation [33].”
BackgroundThe biochemical basis of hereditary fructose intolerance
Bouteldja, N., & Timson, D. J. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9053-2 · Cited by 125
Muscle Glycogenosis Due to Phosphoglucomutase 1 Deficiency
Stojkovic, T., Vissing, J., Petit, F. M., Piraud, M., Ørngreen, M. C., Andersen, G., Claeys, K. G., Wary, C., Hogrel, J., & Laforêt, P. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0901158 · Cited by 117
Transcriptional control of genes that regulate glycolysis and gluconeogenesis in adult liver
Lemaigre, F. P., & Rousseau, G. G. (1994) · Biochemical Journal · doi:10.1042/bj3030001 · Cited by 108 · cited 1×
“Glyceraldehyde 3-phosphate is sequentially transformed into 1,3-bisphosphoglycerate, 3-phosphoglycerate, 2-phosphoglycerate, phosphoenolpyruvate and pyruvate [51].”
BackgroundLiver glycogen turnover in fed and fasted humans
Magnusson, I., Rothman, D. L., Jucker, B., Cline, G. W., Shulman, R. G., & Shulman, G. I. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.5.e796 · Cited by 107 · cited 1×
“However, the capacity to store glycogen in the liver after carbohydrate overfeeding is limited and continued accumulation of liver glycogen, when the reserve is complete, is attenuated by an increase in glycogen release that occurs with increasing glycogen content [34].”
BackgroundIdentification of the Citrate-binding Site of Human ATP-Citrate Lyase Using X-ray Crystallography
Sun, T., Hayakawa, K., Bateman, K., & Fraser, M. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.078667 · Cited by 106
GALT deficiency causes UDP-hexose deficit in human galactosemic cells
Lai, K. (2003) · Glycobiology · doi:10.1093/glycob/cwg033 · Cited by 105
Magnusson, I., Rothman, D. L., Gerard, D. P., Katz, L. D., & Shulman, G. I. (1995) · Diabetes · doi:10.2337/diab.44.2.185 · Cited by 97 · cited 1×
“The transitory effect of glucagon on hep-atic glucose production is not caused by depletion of hepatic glycogen stores [63].”
BackgroundBan, N., Yamada, Y., Someya, Y., Miyawaki, K., Ihara, Y., Hosokawa, M., Toyokuni, S., Tsuda, K., & Seino, Y. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1409 · Cited by 95
Hayee, B., Antonopoulos, A., Murphy, E. J., Rahman, F. Z., Sewell, G., Smith, B. N., McCartney, S., Furman, M., Hall, G., Bloom, S. L., et al. (2011) · Glycobiology · doi:10.1093/glycob/cwr023 · Cited by 91
Bandsma, R., Prinsen, B. H. C. M. T., der Velden, M. G. M. D. S., Rake, J. P., Boer, T. S., Smit, G., Reijngoud, D., & Kuipers, F. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e31816c9013 · Cited by 89 · cited 1×
“Dietary management to promote normal glucose levels improves plasma level of triacylglycerol but does not usually normalize it [75].”
BackgroundViolante, S. N., IJlst, L., Brinke, H. T., de Almeida, I. T., Wanders, R. J. A., Ventura, F. V., & Houten, S. M. (2013) · The FASEB Journal · doi:10.1096/fj.12-216689 · Cited by 84 · cited 1×
“The formation of acetyl-carnitine al-lowsthe exit ofacetyl groupsfromthe mitochondria into thecyto-plasm [55].”
BackgroundRegulation of the structure and activity of pyruvate carboxylase by acetyl CoA
Adina-Zada, A., Zeczycki, T. N., & Attwood, P. V. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.11.015 · Cited by 81 · cited 2×
“During fasting, pyruvate carboxylation in the liver is activated to produce glucose whereas pyruvate decarboxylation by the PDH complex to oxidize glucose is suppressed [62].”
BackgroundUDP-glucose dehydrogenase: structure and function of a potential drug target
Egger, S., Chaikuad, A., Kavanagh, K. L., Oppermann, U., & Nidetzky, B. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381378 · Cited by 80 · cited 2×
“The enzyme UDP–glucose dehydrogenase encoded by the gene UGDH converts UDP–glucose into UDP–glucuronate through two success-iveNAD + -dependentoxidationsteps[38].”
BackgroundCameron, J. M., Levandovskiy, V., MacKay, N., Utgikar, R., Ackerley, C. A., Chiasson, D. A., HALLIDAY, W. C., Raiman, J., & Robinson, B. H. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.07.012 · Cited by 72
Adkins, A., Basu, R., Persson, M., Dicke, B., Shah, P., Vella, A., Schwenk, W. F., & Rizza, R. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2213 · Cited by 67
Iynedjian, P. B., Marie, S., Gjinovci, A., Genin, B., Deng, S. P., Buhler, L., Morel, P., & Mentha, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117880 · Cited by 65 · cited 3×
“In cultured hepatocytes obtained from human liver biopsies, glucokinase accounts for 95% of the glucose phosphorylation activity [11].”
BackgroundQuaternary structure of human fatty acid synthase by electron cryomicroscopy
Brink, J., Ludtke, S. J., Yang, C.-Y., Gu, Z.-W., Wakil, S. J., & Chiu, W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012589499 · Cited by 64 · cited 1×
“Each of the two identical dimers possesses seven structural and functional domains [58].”
BackgroundOrganization of the Human GLUT2 (Pancreatic β-Cell and Hepatocyte) Glucose Transporter Gene
Takeda, J., Kayano, T., Fukomoto, H., & Bell, G. I. (1993) · Diabetes · doi:10.2337/diab.42.5.773 · Cited by 60
Quick, C. B., Fisher, R. A., & Harris, H. (1974) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1974.tb03366.x · Cited by 49 · cited 2×
“Human PGM-1 is expressed in liver and muscle, being a highly polymorphic protein [22].”
BackgroundYki-Järvinen, H., Vogt, C., Iozzo, P., Pipek, R., Daniels, M. C., Virkamäki, A., Mäkimattila, S., Mandarino, L. J., DeFronzo, R. A., McClain, D. A., et al. (1997) · Diabetologia · doi:10.1007/s001250050645 · Cited by 46
Wang, J., Liu, X., Liang, Y., Li, L., & Su, X. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.07.040 · Cited by 40 · cited 1×
“1 [45].”
Enzymatic properties of the N- and C-terminal halves of human hexokinase II
Ahn, K. J., Kim, J.-S., Yun, M., Park, J. H., & Lee, J.-D. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.6.350 · Cited by 35 · cited 1×
“Unlike other hexokinases, human glucok-inase is not inhibited by its product, glucose 6-phosphate, and has lower molecular mass [11,12].”
BackgroundOndrušková, N., Honzík, T., Vondráčková, A., Tesařová, M., Zeman, J., & Hansíková, H. (2014) · PubMed · Cited by 35
SUMOylation of Pancreatic Glucokinase Regulates Its Cellular Stability and Activity*
Aukrust, I., Bjørkhaug, L., Negahdar, M., Molnes, J., Johansson, B. B., Muller, Y. M. F., Haas, W., Gygi, S. P., Sövik, O., Flatmark, T., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.393769 · Cited by 34 · cited 1×
“Recombinant pancreatic and liver human glucokinase undergo post-translational modification by small ubiquitin-like modifier (SUMO) proteins, but the physiological relevance of this finding is unclear [14].”
BackgroundIdentification of human phosphoglucomutase 3 (PGM3) as N-acetylglucosamine-phosphate mutase (AGM1).
Pang, H., Koda, Y., Soejima, M., & Kimurâ, H. (2002) · PubMed · doi:10.1017/s0003480002001033 · Cited by 30
Peng, H., & Chang, H. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80213-e · Cited by 30
Haller, J. F., Krawczyk, S. A., Gostilovitch, L., Corkey, B. E., & Zoeller, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.007 · Cited by 30
Structural characterization of the apo form and NADH binary complex of human lactate dehydrogenase
Dempster, S., Harper, S. J., Moses, J. E., & Dreveny, I. (2014) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s1399004714005422 · Cited by 30 · cited 1×
“Lactate is then transported to the liver where LDH acts in the opposite direction, generating pyruvate to produce glucose via the gluconeogenesis pathway [67].”
BackgroundPang, H., Koda, Y., Soejima, M., & Kimurâ, H. (2002) · Annals of Human Genetics · doi:10.1046/j.1469-1809.2002.00103.x · Cited by 30
Fat and Carbohydrate Metabolism During Exercise in Phosphoglucomutase Type 1 Deficiency
Preisler, N. R., Laforêt, P., Echaniz‐Laguna, A., Ørngreen, M. C., Lonsdorfer‐Wolf, E., Doutreleau, S., Gény, B., Stojkovic, T., Piraud, M., Petit, F. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1651 · Cited by 29
Ogawa, A., Ogawa, E., Yamamoto, S., Fukuda, T., Sugie, H., & Kohno, Y. (2010) · Pediatrics International · doi:10.1111/j.1442-200x.2010.03073.x · Cited by 27
Moon, S. D., Kim, J., Han, J.-H., Ko, S., Ahn, Y., Kim, J.-H., Yang, S.-H., & Song, K. (2010) · Metabolism · doi:10.1016/j.metabol.2009.12.021 · Cited by 27 · cited 1×
“Affected patients usually present with episodes of severe hyper-ventilation due to lactic acidosis and hypoglycaemia occurring with fasting [66].”
BackgroundStiers, K. M., Kain, B. N., Graham, A. C., & Beamer, L. J. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.02.032 · Cited by 26
Yu, Q., & Zheng, X. (2011) · Biochemical Journal · doi:10.1042/bj20111598 · Cited by 23
Autoregulation of Glucose Production
Tappy, L., Jéquier, E., & Schneiter, P. (2000) · Physiology · doi:10.1152/physiologyonline.2000.15.4.198 · Cited by 22 · cited 1×
“The suppression of glycogenolysis and to a lesser extent gluconeogenesis and the activation of glycogen synthesis during the post-prandial period is mainly driven by stimulation of insulin secretion and suppression of glucagon secretion [64].”
BackgroundPaksu, M. Ş., Kalkan, G., Aşılıoğlu, N., Paksu, Ş., & Dinler, G. (2011) · Pediatric Emergency Care · doi:10.1097/pec.0b013e31823b412d · Cited by 19 · cited 1×
“The dephosphorylation of fructose 1,6-bisphosphate renders fructose 6-phosphate, which istransformed into glucose 6-phosphate [70].”
BackgroundMihout, F., Devuyst, O., BENSMAN, A., Brochériou, I., Ridel, C., Wagner, C. A., Mohebbi, N., Boffa, J., Plaisier, E. M., & Ronco, P. M. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu018 · Cited by 19
Inherent lipid metabolic dysfunction in glycogen storage disease IIIa
Li, X., Gong, Q., Ling, Y., Huang, C., Yu, D., Gu, L., Liao, X.-W., Zhang, D., Hu, X., Han, Y., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.096 · Cited by 18
Glycogenin-2 Is Dispensable for Liver Glycogen Synthesis and Glucagon-Stimulated Glucose Release
Irgens, H. U., Fjeld, K., Johansson, B. B., Ringdal, M., Immervoll, H., Leh, S. M., Sövik, O., Johansson, S., Molven, A., & Njølstad, P. R. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4337 · Cited by 14 · cited 1×
“Diabetic males harbouring a GYG2 deletion lack glycogenin-2 in liver biopsy samples, but they are able to synthesize glycogen, likely because they show glycogenin-1 expression in the liver [36].”
BackgroundGrady, G., Thelen, A. M., Albers, J., Ju, T., Guo, J., Barycki, J. J., & Simpson, M. A. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00259 · Cited by 11
Brockhausen, I., Nair, D. G., Chen, M., Yang, X., Allingham, J. S., Szarek, W. A., & Anastassiades, T. (2015) · Biochemistry and Cell Biology · doi:10.1139/bcb-2015-0115 · Cited by 9
Ma, Y., Ghoshdastider, U., Wang, J., Ye, W., Dötsch, V., Filipek, S., Bernhard, F., & Wang, X. (2012) · Protein Expression and Purification · doi:10.1016/j.pep.2012.09.011 · Cited by 6 · cited 1×
“Glucose 6-phosphate inhibits human GNA1 and the binding site of glucose 6-phosphate has been identified [47].”
Background
Cited by
Lipid metabolism reprogramming and its potential targets in cancer
Cheng, C., Geng, F., Cheng, X., & Guo, D. (2018) · Cancer Communications · doi:10.1186/s40880-018-0301-4 · Cited by 850
Eelen, G., de Zeeuw, P., Treps, L., Harjes, U., Wong, B. W., & Carmeliet, P. (2018) · Physiological Reviews · doi:10.1152/physrev.00001.2017 · Cited by 572
Schranner, D., Kastenmüller, G., Schönfelder, M., Römisch-Margl, W., & Wackerhage, H. (2020) · Sports Medicine - Open · doi:10.1186/s40798-020-0238-4 · Cited by 243
“Here, the remaining amino groups are transported to the liver in the form of alanine to generate ammonia in the urea cycle [55].”
BackgroundMetabolic Dysregulation Contributes to the Progression of Alzheimer’s Disease
Yan, X., Hu, Y., Wang, B., Wang, S., & Zhang, X. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.530219 · Cited by 220
Extraction and Quantitation of Nicotinamide Adenine Dinucleotide Redox Cofactors
Lu, W., Wang, L., Chen, L., Hui, S., & Rabinowitz, J. D. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7014 · Cited by 189
“The liver is a major site of fatty acid synthesis, which requires NADPH (1, 14).”
Background
Metadata
- Authors
- Adeva-Andany, M. M., Pérez-Felpete, N., Fernández-Fernández, C., Donapetry-García, C., & Pazos-García, C.
- Affiliations
- Nephrology Division, Hospital General Juan Cardona, c/ Pardo Bazán s/n, 15406 Ferrol, Spain
- Complejo Hospitalario Universitario de Ferrol (ES)
- Venue
- Bioscience Reports
- Publisher
- Portland Press Ltd.
- Published
- 2016-11-29
- Volume
- 36
- Issue
- 6
- ISSN
- 0144-8463 (ISSN-L)
- 1573-4935
- PMC
- PMC5293555
- OpenAlex
- W2528211973
- Cited by
- 372
- References
- 81
- Citations by year
- 2026: 27 · 2025: 52 · 2024: 56 · 2023: 55 · 2022: 48 · 2021: 44 · 2020: 41 · 2019: 26 · 2018: 17 · 2017: 6
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Bioscience Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- hepatic glucose metabolism, glucokinase, glucose-6-phosphate, glycogen synthesis, UDP-glucuronate, glycosylation, hexosamine biosynthetic pathway, UDP-N-acetylglucosamine, fructose-6-phosphate, acetyl-CoA, fatty acid synthesis, pentose phosphate pathway, NADPH, gluconeogenesis, obesity, diabetes mellitus, TCA cycle
- MeSH terms
- Glucose, Glycosylation, Humans, Liver, Protein Processing, Post-Translational, Signal Transduction, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.